InsiderTrades

Form 4 for ONC BeOne Medicines Ltd.

Accepted 2026-06-15 17:55:11 ET · period of report 2026-06-11 · accession 0001980648-26-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-15 17:55 2026-06-11 ONC Lee Chan Henry SVP, GC A - Grant $0.00 +45.1K 346.6K +15% $0
D 2026-06-15 17:55 2026-06-11 ONC Lee Chan Henry SVP, GC S - Sale $257.63 -428 0 -100% -$110.3K
D 2026-06-15 17:55 2026-06-11 ONC Lee Chan Henry SVP, GC A - Grant $0.00 +87.3K 87.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2026-06-11 A A 45,071 $0.00 346,554 D — — (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
2 Common American Depositary Shares 2026-06-11 S D 428 $257.63 0 D — — (F2) Each American Depositary Share represents 13 Ordinary Shares. (F3) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
3 Derivative Share Option (Right to Buy) 2026-06-11 A A 87,308 $0.00 87,308 D $20.81 · — to 2036-06-10 87,308 Ordinary Shares (F4) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. (F4) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. (F5) These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.